Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1×APP transgenic model of Alzheimer's disease
- 1 November 2006
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 27 (11) , 1658-1672
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- β-Amyloid-Stimulated Microglia Induce Neuron Death via Synergistic Stimulation of Tumor Necrosis Factor α and NMDA ReceptorsJournal of Neuroscience, 2005
- Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic MiceNeuron, 2005
- A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide – the first step of a fatal cascadeJournal of Neurochemistry, 2004
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Immunocytochemically defined interneuron populations in the hippocampus of mouse strains used in transgenic technologyHippocampus, 2004
- Interneuron Diversity series: Hippocampal interneuron classifications – making things as simple as possible, not simplerTrends in Neurosciences, 2003
- Early loss of interneurons and delayed subunit-specific changes in GABAA-receptor expression in a mouse model of mesial temporal lobe epilepsyHippocampus, 2000
- Cell surface domain specific postsynaptic currents evoked by identified GABAergic neurones in rat hippocampus in vitroThe Journal of Physiology, 2000
- ALZHEIMER'S DISEASE: Genetic Studies and Transgenic ModelsAnnual Review of Genetics, 1998
- Molecular and Pharmacological Characterization of Native Cortical γ-Aminobutyric AcidA Receptors Containing Both α1 and α3 SubunitsJournal of Biological Chemistry, 1996